Antiatherosclerotic Potential of Clopidogrel: Antioxidant and Anti-Inflammatory Approaches

Table 2

Change in mean plasma levels of hs-CRP, MDA, and GSH in normal control (NC), atherogenic control (AC), vehicle control (VC), and clopidogrel treated groups.

Parameters	Groups
	Clopidogrel treated	AC	NC	VC
Plasma GSH (mmol/L)	0.741±0.02^∗∗	0.56±0.02^∗	1.11±0.03	0.53±0.01^N
Plasma MDA (𝜇mol/L)	0.29±0.01^∗∗	0.51±0.01^∗	0.13±0.01	0.51±0.01^N
Plasma hsCRP (𝜇g/L)	70.40±4.19^∗∗	134.10±1.20^∗	33.30±0.78	135.70±2.09^N

Results are expressed as mean ± SEM.
^∗𝑃<0.05, as compared to NC group; ^∗∗𝑃<0.05, as compared to AC group.
^NNot significant as compared to AC group.